Skip to main content

Advertisement

SpringerLink
Log in

Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The insulin-like growth factor I receptor (IGF-IR) is expressed in many cell types and is critical for normal growth and development. In the healthy mammary gland, the role of IGF-IR is not fully elucidated. However, IGF-IR, which is primarily expressed in the mammary epithelial cells, is known to play an obligatory role in cellular transformation, facilitating the progression to breast cancer. We have utilized the tetracycline regulatory (tet-on) system to generate an in vitro model system to allow us to further investigate IGF-I/IGF-IR function in mammary epithelial cells. A plasmid construct containing a mutant IGF-I receptor (IGF-IR-DN) fused to the tetracycline operator (tetOPhCMV-IGF-IR-DN) was stably transfected into MCF-7 human breast cancer cells. The conditional regulation of the IGF-IR-DN gene expression was studied in four independent clonal lines. The translated IGF-IR-DN protein was detected only in the stably transfected doxycycline-induced cells, and its expression was up-regulated (three- to sixfold) following induction. IGF-I stimulated cell proliferation diminished (twofold) in doxycycline-induced cells compared to uninduced cells, demonstrating that the transgene construct was functional and ruling out any pleiotropic effect that may be attributed to doxycycline. Interestingly, autophosphorylation of the IGF-IR and phosphorylation of the downstream substrate, insulin receptor substrate-1 (IRS-1), was not inhibited in doxycycline/IGF-I treated cells, suggesting the possibility that activation of downstream substrates other than the IRS-1 may be critical for optimal cell proliferation. This novel in vitro model should allow us to more directly examine the role of IGF-I/IGF-IR signaling and function in mammary epithelial cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goldring, M. B. and Goldring, S. R. (1991). Crit. Rev. Eukaryot. Gene Expr. 4, 301–326.

    Google Scholar 

  2. Werner, H. (1999). In: Contemporary endocrinology: the IGF system. Rosenfield, R. and Roberts, C. Jr. (eds.). Humana Press: Totowa, NJ.

    Google Scholar 

  3. Rubin, R. and Baserga, R. (1995). Lab. Invest. 73, 311–331.

    PubMed  CAS  Google Scholar 

  4. Liu, J., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. (1993). Cell 75, 59–72.

    PubMed  CAS  Google Scholar 

  5. Baker, J., Liu, J. P., Robertson, E. J., and Efstraiadis, A. (1993). Cell 75, 73–82.

    PubMed  CAS  Google Scholar 

  6. DeChiara, T. M., Efstratiadis, A., and Robertson, E. J. (1990). Nature 345, 78–80.

    Article  PubMed  CAS  Google Scholar 

  7. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C.T. Jr. (1995). Endocr. Rev. 16, 143–163.

    Article  PubMed  CAS  Google Scholar 

  8. Lorenzino, L. (1998). Breast Cancer Res. Treat. 47, 235–253.

    Article  Google Scholar 

  9. Rubini, M., Hongo, A., D’Ambrosia, C., and Baserga, R. (1997). Exp. Cell Res. 230, 284–292.

    Article  PubMed  CAS  Google Scholar 

  10. Kaleko, M., Rutter, W. G., and Miller, A. D. (1990). Mol. Cell. Biol. 10, 464–473.

    PubMed  CAS  Google Scholar 

  11. Lee, A. V. and Yee, D. (1995). Biomed. Pharmacother. 49, 415–421.

    Article  PubMed  CAS  Google Scholar 

  12. Pollak, M. N. (1998). Breast Cancer Res. Treat. 47, 209–217.

    Article  PubMed  CAS  Google Scholar 

  13. Werner, H. and LeRoith, D. (2000). Cell. Mol. Life Sci. 57, 932–942.

    Article  PubMed  CAS  Google Scholar 

  14. Turner, B. C., Haffty, B. G., Narayanan, L., et al. (1997). Cancer Res. 57, 3079–3083.

    PubMed  CAS  Google Scholar 

  15. Prager, D., Li, H., Asa, S., and Melmed, S. (1994). Proc. Natl. Acad. Sci. USA 91, 2181–2185.

    Article  PubMed  CAS  Google Scholar 

  16. Valentinis, B. and Baserga, R. (2001). J. Clin. Pathol. 54, 133–137.

    Article  CAS  Google Scholar 

  17. Resnicoff, M., Burgaud, J. L., Rotman, H. L., Abraham, D., and Baserga, R. (1995). Cancer Res. 55, 2463–2469.

    PubMed  CAS  Google Scholar 

  18. Reiss, K., D’Ambrosio, C., Tu, X., Tu, C., and Baserga, R. (1998). Clin. Cancer Res. 4, 2647–2655.

    PubMed  CAS  Google Scholar 

  19. Scotlandi, K., Benini, S., Nanni, P., et al. (1998). Cancer Res. 58, 4127–4131.

    PubMed  CAS  Google Scholar 

  20. Baserga, R. (1999). Exp. Cell Res. 253, 1–6.

    Article  PubMed  CAS  Google Scholar 

  21. Kleinberg, D. L., Feldman, M., and Ruan, W. (2000). J. Mammary Gland Biol. Neoplasia 5, 7–17.

    Article  PubMed  CAS  Google Scholar 

  22. Coppola, D., Ferber, A., Miura, M., et al. (1994). Mol. Cell. Biol. 14, 11663–11669.

    Google Scholar 

  23. Jones, J. I. and Clemmons, D. R. (1995). Endocr. Rev. 16, 3–34.

    Article  PubMed  CAS  Google Scholar 

  24. Hadsell, D. L., Greenberg, N. M., Fligger, J. M., Baumrucker, R. R., and Rosen, J. M. (1996). Endocrinology 137, 321–330.

    Article  PubMed  CAS  Google Scholar 

  25. Neuenshwander, S. R. C. T. Jr., Schwartz, A., Wood, T. L., Roberts, C. T. Jr., Hennighausen, L., and LeRoith, D (1996). J. Clin. Invest. 97, 2225–2232.

    Article  Google Scholar 

  26. Ruan, W. and Kleinberg, D.L. (1999). Endocrinology 140, 5075–5081.

    Article  PubMed  CAS  Google Scholar 

  27. Modha, G., Blanchard, A., Iwasiow, B., et al. (2004). Endocrine Res. In Press.

  28. Butler, A. A., Yakar, S., Gewolb, I. H., Karas, M., Okubo, Y., and LeRoith, D. (1998). Comp. Biochem. Physiol. 121, 19–26.

    Article  CAS  Google Scholar 

  29. Adams, T. E., Epa, V. C., Garrett, P. J., and Ward, C. W. (2000). Cell. Mol. Life Sci. 57, 1050–1093.

    Article  PubMed  CAS  Google Scholar 

  30. Samani, A. A. and Brodt, P. (2001). Surg. Oncol. Clin. N. Am. 10, 289–312.

    PubMed  CAS  Google Scholar 

  31. Khandwala, H. M., McCuthcheon, I. E., Flyvbjerg, A., and Friend, K. E. (2000). Endocr. Rev. 21, 215–244.

    Article  PubMed  CAS  Google Scholar 

  32. Surmacz, E. (2000). J. Mammary Gland Biol. Neoplasia 5, 95–105.

    Article  PubMed  CAS  Google Scholar 

  33. Guvakova, M. A. and Surmacz, E. (1997). Exp. Cell Res. 231, 149–162.

    Article  PubMed  CAS  Google Scholar 

  34. Mauro, L., Salerno, M., Panno, M. L., et al. (2001). Biochem. Biophys. Res. Commun. 28, 685–689.

    Article  CAS  Google Scholar 

  35. Prager, D., Yamasaki, H., Weber, M. M., Gebremedhin, S., and Melmed, S. (1992). J. Clin. Invest. 990, 2117–2122.

    Google Scholar 

  36. Butler, A. A., Blaskesley, V. A., Koval, A., deJong, A., Groffen, J., and LeRoith, D. (1997). J. Biol. Chem. 44, 27660–27664.

    Article  Google Scholar 

  37. Beitner-Johnson, D. and LeRoith, D. (1995). J. Biol. Chem. 270, 5187–5190.

    Article  PubMed  CAS  Google Scholar 

  38. Matsuda, M., Tanaka, S., Nagata, S., Kojima, A., Kurata, T., and Shibuya, M. (1992). Mol. Cell. Biol. 12, 3482–3489.

    PubMed  CAS  Google Scholar 

  39. Ten Hoeve, J., Morris, C., Heisterkamp, H., and Groffen, J. (1993). Oncogene 8, 2469–2474.

    PubMed  Google Scholar 

  40. Beitner-Johnson, D., Blakesley, V. A., Shen-Orr, Z., et al. (1996). J. Biol. Chem. 271, 9287–9290.

    Article  PubMed  CAS  Google Scholar 

  41. Gossen, M. and Bujard, H. (1992). Proc. Natl. Acad. Sci. USA 89, 5547–5551.

    Article  PubMed  CAS  Google Scholar 

  42. Venditti, M., Iwasiow, B., Orr, F. W., and Shiu, R. P. C. (2002). Int. J. Cancer 99, 35–42.

    Article  PubMed  CAS  Google Scholar 

  43. Alfa, M. J. and Jay, F. T. (1988). J. Immunol. 141, 2472–2479.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, Canada

    Marcello Venditti, Robert Shiu &  Yvonne Myal

  2. Department of Pathology, Faculty of Medicine, University of Manitoba, D212-770 Bannatyne Avenue, R3E 0W3, Winnipeg, MB, Canada

    Geetanjalee Modha, Anne Blanchard, Janine Sidorchuk &  Yvonne Myal

Authors
  1. Geetanjalee Modha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Blanchard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janine Sidorchuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcello Venditti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert Shiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yvonne Myal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yvonne Myal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Modha, G., Blanchard, A., Sidorchuk, J. et al. Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells. Endocr 22, 293–303 (2003). https://doi.org/10.1385/ENDO:22:3:293

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:22:3:293

Key Words

Search

Navigation